Compare American Financial Group Inc (AFG) vs Centene Corp (CNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Financial Group Inc vs Centene Corp — how do they compare? American Financial Group Inc trades at $144.65 (market cap $11.97B), while Centene Corp trades at $65 (market cap $32.05B). The key difference: Centene Corp is far larger — about 2.7× American Financial Group Inc's market cap, and American Financial Group Inc pays a 2.44% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| AFG | CNC | |
|---|---|---|
Market Cap | $11.97B | $32.05B |
Sector | Financials | Health |
52-Week High | $148.71 | $68.72 |
52-Week Low | $124.18 | $26.17 |
Enterprise Value | $12.35B | $21.10B |
Dividend Yield | 2.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Financial Group Inc
American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. American also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. American's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.
Read more on AFG →About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →
